MCID: RNL097
MIFTS: 42

Renal Artery Disease

Categories: Cardiovascular diseases, Nephrological diseases

Aliases & Classifications for Renal Artery Disease

MalaCards integrated aliases for Renal Artery Disease:

Name: Renal Artery Disease 12 14 69
Vascular Disorder of Kidney 12
Renal Vascular Disorder 69
Renal Vascular Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2388
ICD9CM 35 593.81
NCIt 47 C35338
UMLS 69 C0268790

Summaries for Renal Artery Disease

MalaCards based summary : Renal Artery Disease, also known as vascular disorder of kidney, is related to hypothyroidism due to iodide transport defect and primary hyperoxaluria. An important gene associated with Renal Artery Disease is REN (Renin), and among its related pathways/superpathways are Development Angiotensin activation of ERK and AGE-RAGE signaling pathway in diabetic complications. The drugs Dopamine and Fenoldopam have been mentioned in the context of this disorder. Affiliated tissues include kidney, heart and endothelial, and related phenotypes are cardiovascular system and hematopoietic system

Related Diseases for Renal Artery Disease

Diseases related to Renal Artery Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 98)
id Related Disease Score Top Affiliating Genes
1 hypothyroidism due to iodide transport defect 10.5 ACE REN
2 primary hyperoxaluria 10.4 ACE REN
3 mody, type ii 10.4 ACE REN
4 listeriosis 10.4 ACE REN
5 non-congenital cyst of kidney 10.4 ACE REN
6 voyeurism 10.4 ACE REN
7 cataract, autosomal dominant congenital 4 10.3 ACE AGTR1
8 pulmonary valve insufficiency 10.3 ACE REN
9 microphthalmia, isolated, with coloboma 7 10.3 ACE REN
10 potato nose 10.3 ACE AGTR1
11 synovial chondromatosis 10.3 ACE NPPA
12 repetitive stress injuries 10.3 NPPA REN
13 idiopathic juxtafoveal retinal telangiectasia 10.3 ACE NPPA
14 retinitis pigmentosa 17 10.3 ACE AGTR1
15 cystic fibrosis and congenital absence of the vas deferens 10.3 AGTR1 REN
16 suppurative otitis media 10.3 ACE NPPA
17 cystinosis 10.3 ACE REN
18 laryngostenosis 10.3 ACE AGTR1
19 hypertrichosis of eyelid 10.2 ACE AGTR1
20 adams-oliver syndrome 5 10.2 ACE REN
21 islet cell tumor 10.2 ACE NOS3
22 pediatric angiosarcoma 10.2 ACE REN
23 silver-russell syndrome due to 11p15 microduplication 10.2 NPPA REN
24 munchausen by proxy 10.2 ACE NOS3
25 hepatocellular adenoma 10.2 ACE NOS3
26 urinary bladder posterior wall cancer 10.2 NPPA REN
27 artery disease 10.2
28 acute liver failure 10.2 NPPA REN
29 capillary hemangioma 10.1 NOS3 REN
30 focal dystonia 10.1 ACE NOS3
31 pyriform sinus cancer 10.1 NOS3 NPPA
32 episodic ataxia 10.1 ACE AGTR1
33 renal fibrosis 10.1 ACE NOS3
34 cervical mullerian papilloma 10.1 ACE EPO
35 atrial septal defect 7, with or without av conduction defects 10.0 ACE NPPA REN
36 hypodontia of incisors and premolars 10.0 ACE NPPA REN
37 adenocarcinoma 10.0 ACE AGTR1 REN
38 fibular aplasia ectrodactyly 10.0 ACE AGTR1 REN
39 myopia 10.0 ACE NPPA REN
40 cascade stomach 10.0 ACE AGTR1 REN
41 renal tubular dysgenesis 10.0 ACE AGTR1 REN
42 polymicrogyria, bilateral frontoparietal 10.0 AGTR1 NOS3
43 congenital bilateral megacalycosis 9.9 ACE AGTR1 REN
44 prostate neuroendocrine neoplasm 9.9 ACE AGTR1 REN
45 craniosynostosis 7 9.9 ACE NPPA REN
46 malignant type ab thymoma 9.9 ACE AGTR1 REN
47 preeclampsia/eclampsia 1 9.9 AGTR1 NOS3
48 renal artery atheroma 9.9
49 pyelonephritis 9.8 ACE NOS3 REN
50 panuveitis 9.8 AGTR1 NPPA REN

Comorbidity relations with Renal Artery Disease via Phenotypic Disease Network (PDN): (show all 15)


Acute Cystitis Acute Kidney Failure
Chronic Kidney Failure Chronic Myocardial Ischemia
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Intermediate Coronary Syndrome Ischemic Heart Disease
Kidney Disease Malignant Renovascular Hypertension
Mitral Valve Disease Peripheral Vascular Disease
Renal Artery Atheroma

Graphical network of the top 20 diseases related to Renal Artery Disease:



Diseases related to Renal Artery Disease

Symptoms & Phenotypes for Renal Artery Disease

MGI Mouse Phenotypes related to Renal Artery Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.8 ACE AGTR1 EPO NOS3 NPPA REN
2 hematopoietic system MP:0005397 9.73 EPO NOS3 NPPA REN ACE AGTR1
3 homeostasis/metabolism MP:0005376 9.63 ACE AGTR1 EPO NOS3 NPPA REN
4 muscle MP:0005369 9.26 EPO NOS3 NPPA REN
5 renal/urinary system MP:0005367 9.02 ACE AGTR1 NOS3 NPPA REN

Drugs & Therapeutics for Renal Artery Disease

Drugs for Renal Artery Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 427)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2,Phase 3 51-61-6, 62-31-7 681
2
Fenoldopam Approved Phase 4 67227-56-9, 67227-57-0 3341
3
Metformin Approved Phase 4,Phase 2 657-24-9 14219 4091
4
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 58-61-7 60961
5
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
6
Ticlopidine Approved Phase 4,Phase 3,Phase 2 55142-85-3 5472
7
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541
8
Enalapril Approved, Vet_approved Phase 4,Phase 2,Phase 3 75847-73-3 5362032 40466924
9
Enalaprilat Approved Phase 4,Phase 2,Phase 3 76420-72-9 6917719
10
Tacrolimus Approved, Investigational Phase 4,Phase 3 104987-11-3 445643 439492
11
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
12
Spironolactone Approved Phase 4,Phase 3,Phase 2 1952-01-7, 52-01-7 5833
13
Nifedipine Approved Phase 4,Phase 2,Phase 1 21829-25-4 4485
14
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 772 46507594
15
Ticagrelor Approved Phase 4,Phase 3,Phase 1,Phase 2 274693-27-5 9871419
16
Acetylcysteine Approved, Investigational Phase 4,Phase 3 616-91-1 12035
17
Benzocaine Approved Phase 4,Phase 3 1994-09-7, 94-09-7 2337
18
Regadenoson Approved Phase 4 313348-27-5 219024
19
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
20
Remifentanil Approved Phase 4 132875-61-7 60815
21
Bivalirudin Approved, Investigational Phase 4 128270-60-0 16129704
22
Cilostazol Approved Phase 4 73963-72-1 2754
23
Atenolol Approved Phase 4 29122-68-7 2249
24
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3 58-93-5 3639
25
Trandolapril Approved Phase 4 87679-37-6 5484727
26
Verapamil Approved Phase 4 52-53-9 2520
27
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
28
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
29
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3 128794-94-5 5281078
30
Mycophenolic acid Approved Phase 4,Phase 3 24280-93-1 446541
31
Alendronate Approved Phase 4 121268-17-5, 66376-36-1 2088
32
Phenprocoumon Approved Phase 4 435-97-2 9908 54680692
33
Rivaroxaban Approved Phase 4 366789-02-8
34
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
35
Indapamide Approved Phase 4 26807-65-8 3702
36
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
37
Felodipine Approved, Investigational Phase 4,Phase 1 72509-76-3 3333
38
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
39
Dipyridamole Approved Phase 4 58-32-2 3108
40
Telmisartan Approved, Investigational Phase 4,Phase 3 144701-48-4 65999
41
Lercanidipine Approved, Investigational Phase 4 100427-26-7 65866
42
Iron Approved Phase 4,Phase 2,Phase 1 7439-89-6 23925
43
Bisoprolol Approved Phase 4 66722-44-9 2405
44
Isosorbide Dinitrate Approved Phase 4 87-33-2 6883
45
Nitric Oxide Approved Phase 4,Phase 2 10102-43-9 145068
46
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
47
Allopurinol Approved Phase 4,Phase 3 315-30-0 2094
48
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
49
Calcium Carbonate Approved Phase 4,Phase 3 471-34-1
50
Warfarin Approved Phase 4 81-81-2 6691 54678486

Interventional clinical trials:

(show top 50) (show all 651)

id Name Status NCT ID Phase Drugs
1 Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis Unknown status NCT00711984 Phase 4
2 Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Unknown status NCT01023373 Phase 4 Medical treatment
3 Fenoldopam for Prevention of Acute Kidney Injury Unknown status NCT01690832 Phase 4 standard saline infusion;fenoldopam infusion
4 Effect of Dapagliflozine on Systemic and Renal Endothelial Function Unknown status NCT02501616 Phase 4 Metformin;Dapagliflozin
5 Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients Unknown status NCT01095549 Phase 4
6 Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients Unknown status NCT01101698 Phase 4 Vitamin K2+10μg cholecalciferol;Vitamin D
7 Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Tria Unknown status NCT01918111 Phase 4 adenosine infusion treatment
8 Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients Unknown status NCT01503671 Phase 4 Atorvastatin
9 Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS Study) Unknown status NCT01208714 Phase 4 Optimal medical therapy
10 Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease Unknown status NCT00235287 Phase 4 Candesartan and enalapril;candesartan and enalapril;candesartan and enalapril;candesartan and enalapril
11 Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Unknown status NCT00584350 Phase 4
12 Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE) Unknown status NCT02154854 Phase 4 Tacrolimus targeted half-dose;Tacrolimus targeted plain dose
13 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
14 Effects of Spironolactone in Dialysis Unknown status NCT01128101 Phase 4 Spironolactone
15 Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. Unknown status NCT02087332 Phase 4 Prolonged release Torasemide (Britomar);Torasemide (Diuver)
16 A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment Completed NCT00863707 Phase 4 Regadenoson;Placebo
17 Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery Completed NCT00244530 Phase 4 Nifedipine
18 Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography Completed NCT00209430 Phase 4 Iodixanol 320 mgI/mL
19 Renal Artery Contrast-Free Trial Completed NCT01576835 Phase 4
20 A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery Completed NCT02113150 Phase 4 remifentanil;Ketamine
21 Antithrombotic Regimens and Outcome Completed NCT00448461 Phase 4 heparin;bivalirudin
22 RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography Completed NCT00247325 Phase 4 Iodixanol(Drug)
23 Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease Completed NCT01328470 Phase 4 Clopidogrel, cilostazol
24 Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide Completed NCT00823628 Phase 4 contrast agent (iopromide);contrast agent (iodixanol)
25 Austrian Multivessel Taxus-Stent Registry Completed NCT00738686 Phase 4
26 Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery. Completed NCT00724880 Phase 4 Clopidogrel;Clopidogrel;Clopidogrel
27 Invasive vs Conservative Strategies in Non-ST-elevation Acute Coronary Syndrome and Comorbidities Completed NCT01645943 Phase 4
28 INVEST: INternational VErapamil SR Trandolapril STudy Completed NCT00133692 Phase 4 Verapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ);Atenolol/HCTZ/Trandolapril
29 Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance Completed NCT00129233 Phase 4 Valsartan;Amlodipine
30 Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients Completed NCT01336296 Phase 4 mycophenolic acid
31 Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease Completed NCT00431249 Phase 4 Cilostazol
32 Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease Completed NCT00395382 Phase 4 Alendronate;Placebo
33 Antithrombotic Triple Therapy in Humans Completed NCT01812200 Phase 4 Dabigatran, Ticagrelor, ASA;Rivaroxaban, Ticagrelor, ASA;Phenprocoumon, Ticagrelor, ASA
34 A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction Completed NCT02663713 Phase 4 Ticagrelor;Clopidogrel
35 Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) Completed NCT00390585 Phase 4 Iodixanol 320;Iomeprol 350
36 Vitamin D and Coronary Calcification Study Completed NCT00752102 Phase 4 Calcitriol (Rocaltrol®);Paricalcitol
37 Renal Denervation in Diabetic Nephropathy Completed NCT01588795 Phase 4 Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
38 Lupus Atherosclerosis Prevention Study Completed NCT00120887 Phase 4 Atorvastatin
39 ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis Completed NCT00379899 Phase 4 cinacalcet
40 Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial Completed NCT01123291 Phase 4
41 China Medical University Hospital (CMUH) Triapin Listing Completed NCT00841880 Phase 4 Ramipril + Felodipine;Ramipril;Ramipril
42 Arterial pH and Total Body Nitrogen Balances in APD Completed NCT00586131 Phase 4 ammonium chloride or sodium citrate/citric acid;Sodium citrate/citratic acid
43 Parathyroidectomy in Endstage Renal Disease Completed NCT00745719 Phase 4
44 Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)? Completed NCT01295567 Phase 4 Dipyridamole;placebo
45 A Trial of Telmisartan Prevention of Cardiovascular Disease Completed NCT01075698 Phase 4 Non-ARB (standard therapy);ARB (Telmisartan)
46 Zainidip in Renal Artery Stenosis Completed NCT02594410 Phase 4 Aspirine;Clopidogrel;Lercanidipine
47 Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients Completed NCT01250405 Phase 4 Cinacalcet;Placebo
48 The RAS, Fibrinolysis and Cardiopulmonary Bypass Completed NCT00607672 Phase 4 Placebo;Ramipril;Candesartan
49 The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients Completed NCT03286712 Phase 4 Renogen
50 Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Completed NCT03011775 Phase 4 Pioglitazone 15 mg Tablet;Isosorbide Dinitrate 10Mg Tablet;Acetylsalicylic Acid 75Mg Tablet;Bisoprolol Fumarate 2.5 MG Oral Tablet;Rosuvastatin Calcium 20 MG Oral Tablet;ramipril 5 MG

Search NIH Clinical Center for Renal Artery Disease

Genetic Tests for Renal Artery Disease

Anatomical Context for Renal Artery Disease

MalaCards organs/tissues related to Renal Artery Disease:

39
Kidney, Heart, Endothelial, Bone, Lung, Testes, Liver

Publications for Renal Artery Disease

Articles related to Renal Artery Disease:

(show all 25)
id Title Authors Year
1
Renovascular heart failure: heart failure in patients with atherosclerotic renal artery disease. ( 27052017 )
2016
2
Ex vivo renal artery reconstruction for complex renal artery disease. ( 24594447 )
2014
3
Prevalence of renal artery disease and its prognostic significance in patients undergoing coronary bypass grafting. ( 25150754 )
2014
4
Our preoccupation with renal artery disease in patients undergoing cardiac surgery: much ado about nothing? ( 24161327 )
2014
5
Long-term follow-up of patients with atherosclerotic renal artery disease. ( 23321402 )
2013
6
MD CT angiography and MR angiography of nonatherosclerotic renal artery disease. ( 21681628 )
2011
7
Endovascular and open revascularization for nonatherosclerotic renal artery disease. ( 21249718 )
2011
8
Vanishing renal artery disease: a segmental arterial mediolysis story. ( 21997510 )
2011
9
Atherosclerotic renal artery disease and heart failure: questions in mind. ( 20466691 )
2010
10
Late outcomes of endovascular and open revascularization for nonatherosclerotic renal artery disease. ( 20855752 )
2010
11
Update on the management of atherosclerotic renal artery disease. ( 19202521 )
2009
12
Atherosclerotic Peripheral Vascular Disease Symposium II: intervention for renal artery disease. ( 19106410 )
2008
13
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography. ( 19110812 )
2008
14
Low frequency of renal artery disease in young ischemic stroke patients. ( 18564822 )
2008
15
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. ( 17499952 )
2008
16
Novel stent system for accurate placement in aorto-ostial renal artery disease: preclinical study in porcine renal artery model. ( 17574168 )
2007
17
Clinical insights into the diagnosis and management of atherosclerotic renal artery disease. ( 16901412 )
2006
18
Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease. ( 16892443 )
2006
19
Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease. ( 16208147 )
2005
20
Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography. ( 16310572 )
2005
21
Surgical revascularization for renal artery disease: current status. ( 15720339 )
2005
22
Genetic risk of atherosclerotic renal artery disease: the candidate gene approach in a renal angiography cohort. ( 15326089 )
2004
23
Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. ( 8272217 )
1993
24
Effect of captopril on the renal veno-arterial gradient of erythropoietin and oxygen in unilateral renal artery disease. ( 8140397 )
1993
25
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease. ( 1815652 )
1991

Variations for Renal Artery Disease

Expression for Renal Artery Disease

Search GEO for disease gene expression data for Renal Artery Disease.

Pathways for Renal Artery Disease

GO Terms for Renal Artery Disease

Biological processes related to Renal Artery Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 blood vessel remodeling GO:0001974 9.48 ACE NOS3
2 regulation of vasoconstriction GO:0019229 9.46 ACE AGTR1
3 regulation of blood vessel size GO:0050880 9.43 NOS3 NPPA
4 kidney development GO:0001822 9.43 ACE AGTR1 REN
5 beta-amyloid metabolic process GO:0050435 9.4 ACE REN
6 regulation of blood vessel diameter GO:0097746 9.37 ACE AGTR1
7 angiotensin maturation GO:0002003 9.32 ACE REN
8 regulation of systemic arterial blood pressure by renin-angiotensin GO:0003081 9.16 ACE AGTR1
9 renin-angiotensin regulation of aldosterone production GO:0002018 8.96 AGTR1 REN
10 regulation of blood pressure GO:0008217 8.92 ACE NOS3 NPPA REN

Molecular functions related to Renal Artery Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 endopeptidase activity GO:0004175 8.96 ACE REN
2 bradykinin receptor binding GO:0031711 8.62 ACE AGTR1

Sources for Renal Artery Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....